Everything Lupus: Resource Hub
Anifrolumab (Saphnelo) listed in NS
Read
The Canadian Immunocompromised Advocacy Network (CIAN) – Advocating For Immunocompromised People Across Canada
Read
Potential treatment for COVID-19 should not harm Canadians living with lupus
Read
COVID-19 AND YOUR EMPLOYMENT RIGHTS
Read
Lupus Canada hosted a Facebook Live Q&A with Dr. Matsos on Tuesday, March 31. Dr. Matsos answered questions specific to COVID-19 and its impact on lupus.
Read
The Canadian Rheumatology Association has released their position statement on COVID-19 and Hydroxychloroquine Supply
Read
Canadian lupus patients missing critical drug after claims it treats coronavirus.
Read
“Hydroxychloroquine has long been a standard treatment for lupus and rheumatoid arthritis patients.
Read
Living Through COVID-19 With A Weakened Immune System
Read
COVID-19: Canada secures order for five million pills of anti-malaria medication eyed by U.S. as treatment
Read
